{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:39:38Z","timestamp":1790635178731,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Carl Gustav Carus Dresden an der Technischen Universit\u00e4t Dresden"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Placenta accreta spectrum (PAS) disorders can cause major intrapartum haemorrhage. The optimal management approach is not yet defined. We analysed available cases from a tertiary perinatal centre to compare the outcome of different individual management strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A monocentric retrospective analysis was performed in patients with clinically confirmed diagnosis of PAS between 07\/2012 and 12\/2019. Electronic patient and ultrasound databases were examined for perinatal findings, peripartum morbidity including blood loss and management approaches such as (1) vaginal delivery and curettage, (2) caesarean section with placental removal versus left in situ and (3) planned, immediate or delayed hysterectomy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>46 cases were identified with an incidence of 2.49 per 1000 births. Median diagnosis of placenta accreta (56%), increta (39%) or percreta (4%) was made in 35\u00a0weeks of gestation. Prenatal detection rate was 33% for all cases and 78% for placenta increta. 33% showed an association with placenta praevia, 41% with previous caesarean section and 52% with previous curettage. Caesarean section rate was 65% and hysterectomy rate 39%. In 9% of the cases, the placenta primarily remained in situ. 54% of patients required blood transfusion. Blood loss did not differ between cases with versus without prenatal diagnosis (<jats:italic>p<\/jats:italic>\u2009=\u20090.327). In known cases, an attempt to remove the placenta did not show impact on blood loss (<jats:italic>p<\/jats:italic>\u2009=\u20090.417).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PAS should be managed in an optimal setting and with a well-coordinated team. Experience with different approaches should be proven in prospective multicentre studies to prepare recommendations for expected and unexpected need for management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00404-020-05875-x","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T05:02:52Z","timestamp":1607317372000},"page":"1451-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Placenta accreta spectrum disorders\u2014experience of management in a German tertiary perinatal centre"],"prefix":"10.1007","volume":"303","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-2113","authenticated-orcid":false,"given":"Anja","family":"Bluth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schindelhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Nitzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cahit","family":"Birdir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"issue":"13","key":"5875_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/1471-0528.15927","volume":"126","author":"L Thurn","year":"2019","unstructured":"Thurn L, Wikman A, Westgren M, Lindqvist PG (2019) Massive blood transfusion in relation to delivery: incidence, trends and risk factors: a population-based cohort study. BJOG 126(13):1577\u20131586. https:\/\/doi.org\/10.1111\/1471-0528.15927","journal-title":"BJOG"},{"issue":"3","key":"5875_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ajog.2019.01.233","volume":"221","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, Bunce C, Gr\u00f8nbeck L, Langhoff-Roos J (2019) Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol 221(3):208\u2013218. https:\/\/doi.org\/10.1016\/j.ajog.2019.01.233","journal-title":"Am J Obstet Gynecol"},{"key":"5875_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2147\/IJWH.S218933","volume":"11","author":"NC Perlman","year":"2019","unstructured":"Perlman NC, Carusi DA (2019) Retained placenta after vaginal delivery: risk factors and management. Int J Womens Health 11:527\u2013534. https:\/\/doi.org\/10.2147\/IJWH.S218933","journal-title":"Int J Womens Health"},{"key":"5875_CR4","doi-asserted-by":"publisher","first-page":"1507674","DOI":"10.1155\/2018\/1507674","volume":"2018","author":"HC Bartels","year":"2018","unstructured":"Bartels HC, Postle JD, Downey P, Brennan DJ (2018) Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis Markers 2018:1507674. https:\/\/doi.org\/10.1155\/2018\/1507674","journal-title":"Dis Markers"},{"issue":"3","key":"5875_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ijgo.12407","volume":"140","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet 140(3):265\u2013273. https:\/\/doi.org\/10.1002\/ijgo.12407","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"5875_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ogc.2012.12.002","volume":"40","author":"AC Wortman","year":"2013","unstructured":"Wortman AC, Alexander JM (2013) Placenta accreta, increta, and percreta. Obstet Gynecol Clin North Am 40(1):137\u2013154. https:\/\/doi.org\/10.1016\/j.ogc.2012.12.002","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"5","key":"5875_CR7","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","volume":"192","author":"S Wu","year":"2005","unstructured":"Wu S, Kocherginsky M, Hibbard JU (2005) Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 192(5):1458\u20131461. https:\/\/doi.org\/10.1016\/j.ajog.2004.12.074","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"5875_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/uog.17417","volume":"49","author":"A Bhide","year":"2017","unstructured":"Bhide A, Sebire N, Abuhamad A, Acharya G, Silver R (2017) Morbidly adherent placenta: the need for standardization. Ultrasound Obstet Gynecol 49(5):559\u2013563. https:\/\/doi.org\/10.1002\/uog.17417","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5875_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejogrb.2019.09.021","volume":"242","author":"A Garofalo","year":"2019","unstructured":"Garofalo A, Pilloni E, Alemanno MG et al (2019) Ultrasound accuracy in prenatal diagnosis of abnormal placentation of posterior placenta previa. Eur J Obstet Gynecol Reprod Biol 242:86\u201391. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.09.021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"5875_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/uog.14952","volume":"47","author":"SL Collins","year":"2016","unstructured":"Collins SL, Ashcroft A, Braun T et al (2016) Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol 47(3):271\u2013275. https:\/\/doi.org\/10.1002\/uog.14952","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"5875_CR11","doi-asserted-by":"publisher","first-page":"443.e1","DOI":"10.1016\/j.ajog.2018.01.017","volume":"218","author":"Y Melcer","year":"2018","unstructured":"Melcer Y, Jauniaux E, Maymon S et al (2018) Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. Am J Obstet Gynecol 218(4):443.e1-443.e8. https:\/\/doi.org\/10.1016\/j.ajog.2018.01.017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"5875_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/GCO.0b013e328342b730","volume":"23","author":"CH Comstock","year":"2011","unstructured":"Comstock CH (2011) The antenatal diagnosis of placental attachment disorders. Curr Opin Obstet Gynecol 23(2):117\u2013122. https:\/\/doi.org\/10.1097\/GCO.0b013e328342b730","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"6","key":"5875_CR13","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00404-019-05338-y","volume":"300","author":"BM Mulla","year":"2019","unstructured":"Mulla BM, Weatherford R, Redhunt AM et al (2019) Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa. Arch Gynecol Obstet 300(6):1601\u20131606. https:\/\/doi.org\/10.1007\/s00404-019-05338-y","journal-title":"Arch Gynecol Obstet"},{"key":"5875_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1684471","author":"M Couret","year":"2019","unstructured":"Couret M, Huang Y, Khoury-Collado F et al (2019) Patterns of care for women with placenta accreta spectrum. J Matern Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2019.1684471","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5875_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejogrb.2019.04.032","volume":"237","author":"J Stanleigh","year":"2019","unstructured":"Stanleigh J, Michaeli J, Armon S et al (2019) Maternal and neonatal outcomes following a proactive peripartum multidisciplinary management protocol for placenta creta spectrum as compared to the urgent delivery. Eur J Obstet Gynecol Reprod Biol 237:139\u2013144. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.04.032","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5875_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1676411","author":"VM Fratto","year":"2019","unstructured":"Fratto VM, Conturie CL, Ballas J et al (2019) Assessing the multidisciplinary team approaches to placenta accreta spectrum across five institutions within the University of California fetal Consortium (UCfC). J Matern Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2019.1676411","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"5875_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ajog.2014.11.018","volume":"212","author":"RM Silver","year":"2015","unstructured":"Silver RM, Fox KA, Barton JR et al (2015) Center of excellence for placenta accreta. Am J Obstet Gynecol 212(5):561\u2013568. https:\/\/doi.org\/10.1016\/j.ajog.2014.11.018","journal-title":"Am J Obstet Gynecol"},{"key":"5875_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1702019","author":"T C\u0131rpan","year":"2019","unstructured":"C\u0131rpan T, Akdemir A, Okmen F, Hortu I, Ekici H, Imamoglu M (2019) Effectiveness of segmental resection technique in the treatment of placenta accreta spectrum. J Matern Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2019.1702019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5875_CR19","doi-asserted-by":"publisher","first-page":"174550651987808","DOI":"10.1177\/1745506519878081","volume":"15","author":"A Pi\u00f1as Carrillo","year":"2019","unstructured":"Pi\u00f1as Carrillo A, Chandraharan E (2019) Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure. Womens Health (Lond) 15:1745506519878081. https:\/\/doi.org\/10.1177\/1745506519878081","journal-title":"Womens Health (Lond)"},{"issue":"3","key":"5875_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/1471-0528.15410","volume":"126","author":"J-C Shih","year":"2019","unstructured":"Shih J-C, Liu K-L, Kang J, Yang J-H, Lin M-W, Yu C-U (2019) \u201cNausicaa\u201d compression suture: a simple and effective alternative to hysterectomy in placenta accreta spectrum and other causes of severe postpartum haemorrhage. BJOG 126(3):412\u2013417. https:\/\/doi.org\/10.1111\/1471-0528.15410","journal-title":"BJOG"},{"key":"5875_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.11604\/pamj.2019.33.86.17700","volume":"33","author":"A Slaoui","year":"2019","unstructured":"Slaoui A, Talib S, Nah A et al (2019) Placenta accreta in the department of gynaecology and obstetrics in Rabat, Morocco: case series and review of the literature. Pan Afr Med J 33:86. https:\/\/doi.org\/10.11604\/pamj.2019.33.86.17700","journal-title":"Pan Afr Med J"},{"issue":"6","key":"5875_CR22","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1097\/AOG.0000000000002983","volume":"132","author":"The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine","year":"2018","unstructured":"The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine (2018) Obstetric Care Consensus No. 7: placenta accreta spectrum. Obstet Gynecol 132(6):e259\u2013e275. https:\/\/doi.org\/10.1097\/AOG.0000000000002983","journal-title":"Obstet Gynecol"},{"issue":"3","key":"5875_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ijgo.12410","volume":"140","author":"L Sentilhes","year":"2018","unstructured":"Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet 140(3):291\u2013298. https:\/\/doi.org\/10.1002\/ijgo.12410","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"5875_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijgo.12409","volume":"140","author":"L Allen","year":"2018","unstructured":"Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA, FIGO Placenta Accreta Diagnosis and Management Expert\u00a0Consensus Panel (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management. Int J Gynaecol Obstet 140(3):281\u2013290. https:\/\/doi.org\/10.1002\/ijgo.12409","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"5875_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ijgo.12391","volume":"140","author":"M Cal","year":"2018","unstructured":"Cal M, Ayres-de-Campos D, Jauniaux E (2018) International survey of practices used in the diagnosis and management of placenta accreta spectrum disorders. Int J Gynaecol Obstet 140(3):307\u2013311. https:\/\/doi.org\/10.1002\/ijgo.12391","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"5875_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ijgo.12761","volume":"146","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel (2019) FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 146(1):20\u201324. https:\/\/doi.org\/10.1002\/ijgo.12761","journal-title":"Int J Gynaecol Obstet"},{"key":"5875_CR27","unstructured":"Federal Medical Association of Germany (2017) Hemotherapy guideline for collecting blood and blood components and application of blood products. https:\/\/www.bundesaerztekammer.de\/fileadmin\/user_upload\/downloads\/pdf-Ordner\/MuE\/Richtlinie_Haemotherapie_E_A_2019.pdf"},{"key":"5875_CR28","unstructured":"Peripartal haemorrhage, diagnosis and therapy. Guideline of the German Society of Gynaecology and Obstetrics (S2k-Level, AWMF Registry No. 015\/063, March 2016). http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/015-063.html"},{"key":"5875_CR29","unstructured":"National Cancer Institute, Division of Cancer Treatment and Diagnosis (2018) Common Terminology Criteria for Adverse Events version 5.0"},{"issue":"4","key":"5875_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/ajo.12932","volume":"59","author":"N Yasin","year":"2019","unstructured":"Yasin N, Slade L, Atkinson E, Kennedy-Andrews S, Scroggs S, Grivell R (2019) The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: a ten-year experience. Aust NZ J Obstet Gynaecol 59(4):550\u2013554. https:\/\/doi.org\/10.1111\/ajo.12932","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"5875_CR31","volume-title":"StatPearls","author":"FM Anderson-Bagga","year":"2019","unstructured":"Anderson-Bagga FM, Sze A (2019) Placenta Previa. In: Ddd V (ed) StatPearls. StatPearls Publishing, Treasure Island"},{"issue":"11","key":"5875_CR32","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.jogc.2019.01.016","volume":"41","author":"C Mitric","year":"2019","unstructured":"Mitric C, Desilets J, Balayla J, Ziegler C (2019) Surgical management of the placenta accreta spectrum: an institutional experience. J Obstet Gynaecol Can 41(11):1551\u20131557. https:\/\/doi.org\/10.1016\/j.jogc.2019.01.016","journal-title":"J Obstet Gynaecol Can"},{"key":"5875_CR33","doi-asserted-by":"crossref","unstructured":"Federal statistics agency of Germany, Press release No. 349 of 17 September 2018; 30.5% of hospital deliveries by Caesarean section in 2017. https:\/\/www.destatis.de\/DE\/Presse\/Pressemitteilungen\/2018\/09\/PD18_349_231.html","DOI":"10.4414\/phc-d.2017.01576"},{"issue":"6","key":"5875_CR34","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/uog.20246","volume":"53","author":"G Cali","year":"2019","unstructured":"Cali G, Forlani F, Lees C et al (2019) Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol 53(6):752\u2013760. https:\/\/doi.org\/10.1002\/uog.20246","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5875_CR35","first-page":"825","volume":"58","author":"R Faber","year":"2017","unstructured":"Faber R, Stepan H (2017) Ultrasound assessment of the lower uterine segment in pregnancy. Frauenarzt 58:825\u2013833","journal-title":"Frauenarzt"},{"issue":"8","key":"5875_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1055\/s-0038-1676488","volume":"36","author":"J Philips","year":"2019","unstructured":"Philips J, Gurganus M, DeShields S et al (2019) Prevalence of sonographic markers of placenta accreta spectrum in low-risk pregnancies. Am J Perinatol 36(8):733\u2013780. https:\/\/doi.org\/10.1055\/s-0038-1676488","journal-title":"Am J Perinatol"},{"issue":"4","key":"5875_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/aogs.12081","volume":"92","author":"F Chantraine","year":"2013","unstructured":"Chantraine F, Braun T, Gonser M, Henrich W, Tutschek B (2013) Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand 92(4):439\u2013444. https:\/\/doi.org\/10.1111\/aogs.12081","journal-title":"Acta Obstet Gynecol Scand"},{"key":"5875_CR38","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.galenos.2019.2019.0063","author":"R Imtiaz","year":"2019","unstructured":"Imtiaz R, Masood Z, Husain S, Husain S, Izhar R, Hussain S (2019) A comparison of antenatally and intraoperatively diagnosed cases of placenta accreta spectrum (PAS). J Turk Ger Gynecol Assoc. https:\/\/doi.org\/10.4274\/jtgga.galenos.2019.2019.0063","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"12","key":"5875_CR39","doi-asserted-by":"publisher","first-page":"e6353","DOI":"10.7759\/cureus.6353","volume":"11","author":"MK Marquette","year":"2019","unstructured":"Marquette MK, Sarkodie O, Walker AT, Patterson E (2019) Uterine preservation after vaginal delivery with manual extraction of focal placenta accreta. Cureus 11(12):e6353. https:\/\/doi.org\/10.7759\/cureus.6353","journal-title":"Cureus"},{"issue":"1","key":"5875_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12884-019-2608-9","volume":"19","author":"H Kyozuka","year":"2019","unstructured":"Kyozuka H, Yamaguchi A, Suzuki D et al (2019) Risk factors for placenta accreta spectrum: findings from the Japan environment and Children\u2019s study. BMC Pregnancy Childbirth 19(1):447. https:\/\/doi.org\/10.1186\/s12884-019-2608-9","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"5875_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ajog.2019.11.1246","volume":"222","author":"E Jauniaux","year":"2020","unstructured":"Jauniaux E, Hussein AM, Zosmer N et al (2020) A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta. Am J Obstet Gynecol 222(4):379. https:\/\/doi.org\/10.1016\/j.ajog.2019.11.1246","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"5875_CR42","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1038\/s41379-020-0569-1","volume":"33","author":"JL Hecht","year":"2020","unstructured":"Hecht JL, Baergen R, Ernst LM, Katzman PJ, Jacques SM, Jauniaux E, Khong TY, Metlay LA, Poder L, Qureshi F, Rabban JT 3rd, Roberts DJ, Shainker S, Heller DS (2020) Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol 33(12):2382\u20132396. https:\/\/doi.org\/10.1038\/s41379-020-0569-1","journal-title":"Mod Pathol"},{"issue":"5","key":"5875_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00404-015-4006-5","volume":"293","author":"K Dannheim","year":"2016","unstructured":"Dannheim K, Shainker SA, Hecht JL (2016) Hysterectomy for placenta accreta; methods for gross and microscopic pathology examination. Arch Gynecol Obstet 293(5):951\u2013958. https:\/\/doi.org\/10.1007\/s00404-015-4006-5","journal-title":"Arch Gynecol Obstet"},{"key":"5875_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2020.1716715","volume":"26","author":"JM Palacios-Jaraquemada","year":"2020","unstructured":"Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Mart\u00ednez M, Bruno C (2020) Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med 26:1\u20138. https:\/\/doi.org\/10.1080\/14767058.2020.1716715","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"8","key":"5875_CR45","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1055\/s-0038-1668528","volume":"40","author":"I Biyik","year":"2018","unstructured":"Biyik I, Keskin F, Keskin EU (2018) Conservative Surgical Treatment of a Case of Placenta Accreta. Rev Bras Ginecol Obstet 40(8):494\u2013496. https:\/\/doi.org\/10.1055\/s-0038-1668528","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"2","key":"5875_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tjog.2018.02.017","volume":"57","author":"X Zhao","year":"2018","unstructured":"Zhao X, Tao Y, Du Y et al (2018) The application of uterine wall local resection and reconstruction to preserve the uterus for the management of morbidly adherent placenta: Case series. Taiwan J Obstet Gynecol 57(2):276\u2013282. https:\/\/doi.org\/10.1016\/j.tjog.2018.02.017","journal-title":"Taiwan J Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05875-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05875-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05875-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T08:07:27Z","timestamp":1619770047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05875-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5875"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05875-x","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,7]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This monocentric retrospective cohort analysis involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Research Ethics Commission of the Faculty of Medicine, Technische Universit\u00e4t Dresden, Germany (Ethics approval number: BO-EK-66022020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All data were anonymised for retrospective analysis. Therefore, patient consent was not required for the present study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All data were anonymised for retrospective analysis. Therefore, patient consent was not required for the present study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}